Markets
News
Analysis
User
24/7
Economic Calendar
Education
Data
- Names
- Latest
- Prev
【The Popular Anti-Cancer Drug Regorafenib Has Seen Its Latest Procurement Price Drop To Over 4 Yuan Per Tablet.】At The Site Of The Tenth Batch Of Pharmaceutical Procurements, It Was Learned That The Anti-Tumor Drug Regorafenib, With Annual Sales Exceeding 1 Billion Yuan, Has Seen Its Bidding Price Drop To Around 4 To 6 Yuan Per Tablet, A Decrease Of 90% From The Limit Price. Nanjing Zhengda Tianqing Is Expected To Win The Bid In The First Round. Regorafenib Can Treat Various Cancers, Including Colorectal And Liver Cancer, And Its Original Manufacturer Is Bayer, Which Holds Almost The Entire Market Share Domestically. In This Procurement, Bayer'S Quoted Price Is Approximately 172 Yuan Per Tablet.
Quick access to 24/7
Quick access to more editor-selected real-time news
Exclusive video for free
FastBull VIPject team is dedicated to create exclusive videos
Follow More Symbols
You can add more symbols to your watchlist.
More comprehensive macro data and economic indicators
More comprehensive historical data on indicators to help analyze macro markets
Member-only Database
Comprehensive forex, commodity, and equity market data